Paulex Bio Inc.
Paulex Bio Receives NIH Fast-Track Grant to Advance Beta Cell Regeneration Therapy of PAL-119
PAL-119 is designed to regenerate and restore insulin-producing pancreatic beta cells as a potential disease-modifying therapy for Type 1 and Type 2…